Found: 39
Select item for more details and to access through your institution.
IgG-based B7-H3xCD3 bispecific antibody for treatment of pancreatic, hepatic and gastric cancer.
- Published in:
- Frontiers in Immunology, 2023, p. 01, doi. 10.3389/fimmu.2023.1163136
- By:
- Publication type:
- Article
T cell and antibody kinetics delineate SARS-CoV-2 peptides mediating long-term immune responses in COVID-19 convalescent individuals.
- Published in:
- Science Translational Medicine, 2021, v. 13, n. 590, p. 1, doi. 10.1126/scitranslmed.abf7517
- By:
- Publication type:
- Article
Immunopeptidome Diversity in Chronic Lymphocytic Leukemia Identifies Patients with Favorable Disease Outcome.
- Published in:
- Cancers, 2022, v. 14, n. 19, p. 4659, doi. 10.3390/cancers14194659
- By:
- Publication type:
- Article
HLA-DR Presentation of the Tumor Antigen MSLN Associates with Clinical Outcome of Ovarian Cancer Patients.
- Published in:
- Cancers, 2022, v. 14, n. 9, p. N.PAG, doi. 10.3390/cancers14092260
- By:
- Publication type:
- Article
Receptor Activator of NF-κB (RANK) Confers Resistance to Chemotherapy in AML and Associates with Dismal Disease Course.
- Published in:
- Cancers, 2021, v. 13, n. 23, p. 6122, doi. 10.3390/cancers13236122
- By:
- Publication type:
- Article
An Fc-Optimized CD133 Antibody for Induction of NK Cell Reactivity against B Cell Acute Lymphoblastic Leukemia.
- Published in:
- Cancers, 2021, v. 13, n. 7, p. 1632, doi. 10.3390/cancers13071632
- By:
- Publication type:
- Article
Bispecific Antibodies in Prostate Cancer Therapy: Current Status and Perspectives.
- Published in:
- Cancers, 2021, v. 13, n. 3, p. 549, doi. 10.3390/cancers13030549
- By:
- Publication type:
- Article
Neutralization of B-Cell Activating Factor (BAFF) by Belimumab Reinforces Small Molecule Inhibitor Treatment in Chronic Lymphocytic Leukemia.
- Published in:
- Cancers, 2020, v. 12, n. 10, p. 2725, doi. 10.3390/cancers12102725
- By:
- Publication type:
- Article
HLA Evolutionary Divergence as a Prognostic Marker for AML Patients Undergoing Allogeneic Stem Cell Transplantation.
- Published in:
- Cancers, 2020, v. 12, n. 7, p. 1835, doi. 10.3390/cancers12071835
- By:
- Publication type:
- Article
Induction of NK cell reactivity against acute myeloid leukemia by Fc-optimized CD276 (B7-H3) antibody.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01050-6
- By:
- Publication type:
- Article
Performance of phase‐I dose finding designs with and without a run‐in intra‐patient dose escalation stage.
- Published in:
- Pharmaceutical Statistics, 2023, v. 22, n. 2, p. 236, doi. 10.1002/pst.2268
- By:
- Publication type:
- Article
iVAC-XS15-CLL01: personalized multi-peptide vaccination in combination with the TLR1/2 ligand XS15 in CLL patients undergoing BTK-inhibitor-based regimens.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1441625
- By:
- Publication type:
- Article
The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-33746-3
- By:
- Publication type:
- Article
Long-Term Follow-Up of COVID-19 Convalescents—Immune Response Associated with Reinfection Rate and Symptoms.
- Published in:
- Viruses (1999-4915), 2023, v. 15, n. 10, p. 2100, doi. 10.3390/v15102100
- By:
- Publication type:
- Article
Elevated SARS-CoV-2-Specific Antibody Levels in Patients with Post-COVID Syndrome.
- Published in:
- Viruses (1999-4915), 2023, v. 15, n. 3, p. 701, doi. 10.3390/v15030701
- By:
- Publication type:
- Article
CD105 (Endoglin) as negative prognostic factor in AML.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-54767-x
- By:
- Publication type:
- Article
SARS‐CoV‐2‐reactive T‐cell receptors isolated from convalescent COVID‐19 patients confer potent T‐cell effector function.
- Published in:
- European Journal of Immunology, 2021, v. 51, n. 11, p. 2651, doi. 10.1002/eji.202149290
- By:
- Publication type:
- Article
Phase I study evaluating the Fc-optimized FLT3 antibody FLYSYN in AML patients with measurable residual disease.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01490-w
- By:
- Publication type:
- Article
CD105 (endoglin) as risk marker in AML patients undergoing stem cell transplantation.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Platelet-expressed immune checkpoint regulator GITRL in breast cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 9, p. 2483, doi. 10.1007/s00262-021-02866-y
- By:
- Publication type:
- Article
Expression of the immune checkpoint modulator OX40 indicates poor survival in acute myeloid leukemia.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-19972-1
- By:
- Publication type:
- Article
FusionVAC22_01: a phase I clinical trial evaluating a DNAJB1-PRKACA fusion transcript-based peptide vaccine combined with immune checkpoint inhibition for fibrolamellar hepatocellular carcinoma and other tumor entities carrying the oncogenic driver fusion
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1367450
- By:
- Publication type:
- Article
Protocol of a first-in-human clinical trial to evaluate the safety, tolerability, and preliminary efficacy of the bispecific CD276xCD3 antibody CC-3 in patients with colorectal cancer (CoRe_CC-3).
- Published in:
- Frontiers in Oncology, 2024, p. 01, doi. 10.3389/fonc.2024.1351901
- By:
- Publication type:
- Article
NFAT2 is a critical regulator of the anergic phenotype in chronic lymphocytic leukaemia.
- Published in:
- Nature Communications, 2017, v. 8, n. 1, p. 1, doi. 10.1038/s41467-017-00830-y
- By:
- Publication type:
- Article
A novel flow cytometry‐based assay to measure compromised B cell receptor signaling as a prognostic factor in chronic lymphocytic leukemia.
- Published in:
- Journal of Leukocyte Biology, 2020, v. 108, n. 6, p. 1851, doi. 10.1002/JLB.5TA0320-411RR
- By:
- Publication type:
- Article
Loss of NFAT2 expression results in the acceleration of clonal evolution in chronic lymphocytic leukemia.
- Published in:
- Journal of Leukocyte Biology, 2019, v. 105, n. 3, p. 531, doi. 10.1002/JLB.2AB0218-076RR
- By:
- Publication type:
- Article
Identification of CD105 (endoglin) as novel risk marker in CLL.
- Published in:
- Annals of Hematology, 2022, v. 101, n. 4, p. 773, doi. 10.1007/s00277-022-04756-4
- By:
- Publication type:
- Article
Identification of CD318 (CDCP1) as novel prognostic marker in AML.
- Published in:
- 2020
- By:
- Publication type:
- journal article
DNAM-1/CD226 is functionally expressed on acute myeloid leukemia (AML) cells and is associated with favorable prognosis.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-97400-6
- By:
- Publication type:
- Article
Immunoprofiling of 4-1BB Expression Predicts Outcome in Chronic Lymphocytic Leukemia (CLL).
- Published in:
- Diagnostics (2075-4418), 2021, v. 11, n. 11, p. 2041, doi. 10.3390/diagnostics11112041
- By:
- Publication type:
- Article
Regulation of Platelet-Derived ADAM17: A Biomarker Approach for Breast Cancer?
- Published in:
- Diagnostics (2075-4418), 2021, v. 11, n. 7, p. 1188, doi. 10.3390/diagnostics11071188
- By:
- Publication type:
- Article
Immunopeptidomics-Guided Warehouse Design for Peptide-Based Immunotherapy in Chronic Lymphocytic Leukemia.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.705974
- By:
- Publication type:
- Article
Bispecific NKG2D-CD3 and NKG2D-CD16 Fusion Proteins as Novel Treatment Option in Advanced Soft Tissue Sarcomas.
- Published in:
- Frontiers in Immunology, 2021, v. 11, p. N.PAG, doi. 10.3389/fimmu.2021.653081
- By:
- Publication type:
- Article
Genetic Loss of LCK Kinase Leads to Acceleration of Chronic Lymphocytic Leukemia.
- Published in:
- Frontiers in Immunology, 2020, v. 11, p. N.PAG, doi. 10.3389/fimmu.2020.01995
- By:
- Publication type:
- Article
Phase I/II trial of a peptide-based COVID-19 T-cell activator in patients with B-cell deficiency.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-40758-0
- By:
- Publication type:
- Article
Platelet-Expressed TNFRSF13B (TACI) Predicts Breast Cancer Progression.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.642170
- By:
- Publication type:
- Article
BCR::ABL1 tyrosine kinase inhibitors hamper the therapeutic efficacy of blinatumomab in vitro.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 10, p. 2759, doi. 10.1007/s00432-022-04039-5
- By:
- Publication type:
- Article
An IgG‐based bispecific antibody for improved dual targeting in PSMA‐positive cancer.
- Published in:
- EMBO Molecular Medicine, 2021, v. 13, n. 2, p. 1, doi. 10.15252/emmm.201911902
- By:
- Publication type:
- Article
Soluble NKG2DLs Are Elevated in Breast Cancer Patients and Associate with Disease Outcome.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 7, p. 4126, doi. 10.3390/ijms25074126
- By:
- Publication type:
- Article